Propofol's derivative: A potential drug for erectile dysfunction?

Medical Hypotheses

Volumn 77, Issue 4, 2011, Pages 668-670

  Sweni, Shah ^a   Meenakshisundaram, Ramachandran ^a   Senthilkumaran, S ^b   Thirumalaikolundusubramanian, Ponniah ^a  

^a Chennai Medical College Hospital and Research Centre   (India)

^b Sri Gokulam Hospital and Research Institute   (India)

Author keywords

[No Author keywords available]

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; 4 AMINOBUTYRIC ACID A RECEPTOR BLOCKING AGENT; 4 AMINOBUTYRIC ACID A RECEPTOR STIMULATING AGENT; ADENOSINE TRIPHOSPHATASE (POTASSIUM); ADVANCED GLYCATION END PRODUCT; APOMORPHINE; BACLOFEN; CYCLIC GMP; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; DOPAMINE 3 RECEPTOR; DOPAMINE 4 RECEPTOR; DOPAMINE 5 RECEPTOR; FENCLONINE; FLUPENTIXOL; GUANINE NUCLEOTIDE BINDING PROTEIN; ION CHANNEL; MYOSIN LIGHT CHAIN KINASE; N METHYL DEXTRO ASPARTIC ACID; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; PROPOFOL; PROSTAGLANDIN E1; PROSTAGLANDIN E2; PROSTAGLANDIN F2; SEROTONIN; SEROTONIN RECEPTOR; THROMBOXANE A2;

ANTIEMETIC ACTIVITY; ANTINOCICEPTION; APPETITE; ARTICLE; CALCIUM SIGNALING; CENTRAL NERVOUS SYSTEM; COPULATION; CORPUS CAVERNOSUM; CYTOTOXICITY; ENZYME ACTIVATION; ENZYME ACTIVITY; ERECTILE DYSFUNCTION; HEART PROTECTION; HIPPOCAMPUS; HUMAN; INHIBITION KINETICS; LUMBOSACRAL SPINE; MEDIAL PREOPTIC AREA; NEUROPROTECTION; NONHUMAN; PARAVENTRICULAR THALAMIC NUCLEUS; PENIS ERECTION; PRIAPISM; PYRAMIDAL NERVE CELL; RAPHE NUCLEUS; RETICULAR FORMATION; SCHIZOPHRENIA; SEIZURE; SMOOTH MUSCLE RELAXATION; STRESS; THROMBOCYTE AGGREGATION; TRANQUILIZING ACTIVITY; VASOCONSTRICTION;

ANESTHETICS, INTRAVENOUS; ANIMALS; CALCIUM; DOPAMINE; ERECTILE DYSFUNCTION; GAMMA-AMINOBUTYRIC ACID; MALE; N-METHYLASPARTATE; NITRIC OXIDE; POTASSIUM CHANNELS; PROPOFOL; PROSTAGLANDINS; RATS; RECEPTORS, DOPAMINE D2;

EID: 80052635358     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2011.07.011     Document Type: Article

References (36)

1. Langley M.S., Heel R.C. Propofol: a review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic. Drugs 1988, 35:334-372.
2. Vasileiou I., Xanthos T., Koudouna E., Perrea D., Klonaris C., Katsargyris A., et al. Propofol: a review of its non-anaesthetic effects. Eur J Pharmacol 2009, 605:1-8.
3. Yuan J., Desouza R., Westney O.L., Wang R. Insights of priapism mechanism and rationale treatment for recurrent priapism. Asian J Androl 2008, 10:88-101.
4. Senthilkumaran S., Shah S., Balamurugan G.N., Thirumalaikolundusubramanian P. Propofol and priapism. Indian J Pharmacol 2010, 42:238-239.
5. Vesta K.S., Martina S.D., Kozlowski E.A. Propofol-induced priapism, a case confirmed with rechallenge. Ann Pharmacother 2006, 40:980-982.
6. Fuentes E.J., Garcia S., Garrido M., Lorenzo C., Iglesias J.M., Sola J.E. Successful treatment of propofol-induced priapism with distal glans to corporal cavernosal shunt. Urology 2009, 74:113-115.
7. Andersson K.-E. Pharmacology of penile erection. Pharmacological Reviews 2001, 53:417-450.
8. Gerhardt C.C., van Heerikhuizen H. Functional characteristics of heterologously expressed 5-HT receptors. Eur J Pharmacol 1997, 334:1-23.
9. Bitran D., Hull E.M. Pharmacological analysis of male rat sexual behavior. Neurosci Biobehav Rev 1987, 11:365-389.
10. Kondo Y., Yamanouchi K., Arai Y. P-chlorophenylalanine facilitates copulatory behavior in septal lesioned but not in preoptic lesioned male rats. J Neuroendocrinol 1993, 5:629-633.
11. Svensson L., Hansen S. Spinal monoaminergic modulation of masculine copulatory behavior in the rat. Brain Res 1984, 302:315-321.
12. Marson L., McKenna K. A role for 5-hydroxytryptamine in descending inhibition of spinal sexual reflexes. Exp Brain Res 1992, 88:313-320.
13. Szele F.G., Murphy D.L., Garrick N.A. Effects of fenfluramine, M-chlorophenylpiperazine, and other serotonin-related agonists and antagonists on penile erections in nonhuman primates. Life Sci 1988, 43:1297-1303.
14. Grouzmann A.B.E., Fathi M., Gaillard R.C., Ravussin P. Plasma and cerebrospinal fluid concentrations of neuropeptide Y, serotonin, and catecholamines in patients under propofol or isoflurane anesthesia. Can J Physiol Pharmacol 2000, 78:100-107.
15. Matsuo M., Ayuse T., Oi K., Kataoka Y. Propofol produces anticonflict action by inhibiting 5-HT release in rat dorsal hippocampus. NeuroReport 1997, 8:3087-3090.
16. Fernández-Guasti A., Larsson K., Beyer C. GABAergic control of masculine sexual behavior. Pharmacol Biochem Behav 1986, 24:1065-1070.
17. Fernández-Guasti A., Larsson K., Beyer C. Comparison of the effects of different isomers of bicuculline infused in the preoptic area on male rat sexual behavior. Cell Mol Life Sci 1985, 41:1414-1416.
18. Nadeson R., Goodchild C.S. Antinociceptive properties of propofol: involvement of spinal cord γ-aminobutyric acid receptors. J Pharmacol Exp Ther 1997, 282:1181-1186.
19. Dong X.P., Xu T.L. The actions of propofol on gamma-aminobutyric acid-A and glycine receptors in acutely dissociated spinal dorsal horn neurons of the rat. Anesth Analg 2002, 95:907-914.
20. Kloda A., Martinac B., Adams D.J. Polymodal regulation of NMDA receptor channels. Channels (Austin) 2007, 1:334-343.
21. Melis M.R., Succu S., Iannucci U., Argiolas A. N-Methyl-aspartic acid-induced penile erection and yawning: role of hypothalamic paraventricular nitric oxide. Eur J Pharmacol 1997, 328:115-123.
22. Snyder S.H. Nitric oxide and neurons. Curr Opin Neurobiol 1992, 2:323-327.
23. Zhan R.-Z., Qi S., Wu C., Fujihara H., Taga K., Shimoji K. Intravenous anesthetics differentially reduce neurotransmission damage caused by oxygen-glucose deprivation in rat hippocampal slices in correlation with N-methyl-d-aspartate receptor inhibition. Crit Care Med 2001, 29:808-813.
24. Benassi-Benelli A., Ferrari F., Quarantotti B.P. Penile erection induced by apomorphine and N-n-propyl-norapomorphine in rats. Arch Int Pharmacodyn Ther 1979, 242:241-247.
25. Pehek E.A., Warner R.K., Bazzett T.J., Bitran D., Band L.C., Eaton R.C., et al. Microinjection of cis-flupenthixol, a dopamine antagonist, into the medial preoptic area impairs sexual behavior of male rats. Brain Res 1988, 443:70-76.
26. Borgeat A., Dessibourg C., Popovic V., Meier D., Blanchard M., Schwander D. Propofol and spontaneous movements: an EEG study. Anesthesiology 1991, 74:24-27.
27. Vernet D., Cai L., Garban H., Babbitt M., Murray F., Rajfer J., et al. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type I) and BBZ/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995, 136:5709-5717.
28. Seftel A.D., Vaziri N.D., Ni Z., Razmjouei K., Fogarty J., Hampel N., et al. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through inos or enos. Urology 1997, 50:1016-1026.
29. González-Correa J., Cruz-Andreotti E., Arrebola M., López-Villodres J., Jódar M., De La Cruz J. Effects of propofol on the leukocyte nitric oxide pathway: in vitro and ex vivo studies in surgical patients. Naunyn Schmiedebergs Arch Pharmacol 2008, 376:331-339.
30. Khan M.A., Thompson C.S., Sullivan M.E., Jeremy J.Y., Mikhailidis D.P., Morgan R.J. The role of prostaglandins in the aetiology and treatment of erectile dysfunction. Prostaglandins Leukot Essent Fatty Acids 1999, 60:169-174.
31. Escrig A.N.A., Marin R., Mas M. Repeated PGE1 treatment enhances nitric oxide and erection responses to nerve stimulation in the rat penis by upregulating constitutive NOS isoforms. J Urol 1999, 162:2205-2210.
32. Aoki H., Mizobe T., Nozuchi S., Hiramatsu N. In vivo and in vitro studies of the inhibitory effect of propofol on human platelet aggregation. Anesthesiology 1998, 88:362-370.
33. Hirakata H., Nakamura K., Yokubol B., Toda H., Hatano Y., Urabe N., et al. Propofol has both enhancing and suppressing effects on human platelet aggregation in vitro. Anesthesiology 1999, 91:1361.
34. Andersson K.E., Wagner G. Physiology of penile erection. Physiol Rev 1995, 75:191-236.
35. Tanaka K., Ludwig L.M., Kersten J.R., Pagel P.S., Warltier D.C. Mechanisms of cardioprotection by volatile anesthetics. Anesthesiology 2004, 100:707-721.
36. Toller W.G., Gross E.R., Kersten J.R., Pagel P.S., Gross G.J., Warltier D.C. Sarcolemmal and mitochondrial adenosine triphosphate-dependent potassium channels: mechanism of desflurane-induced cardioprotection. Anesthesiology 2000, 92:1731-1739.